Physician

Thomas Shaughnessy, M.D.

According to 2025 Medicare claims, Thomas Shaughnessy, M.D. (NPI: 1326083379) practices nephrology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Kenton, KY. This provider's primary affiliated billing organization is KIDNEY AND HYPERTENSION CENTER INC (NPI: 1306944871; TIN: 311523745) and primary practice location at 41017-5103. Shaughnessy is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Shaughnessy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 556 traditional Medicare patients, billed 2,406 HCPCS/CPT codes, and received $164,750 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 3,212 prescription claims across 457 beneficiaries totaling $452,758 in drug costs, led by Tavneos (Avacopan). DME data shows 208 claims. Open Payments data shows 6 records totaling $63. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $308,083 to $452,758. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	648	2,290	$212,429
2016	575	2,182	$203,315
2017	600	2,707	$248,860
2018	590	2,416	$227,884
2019	616	2,539	$224,354
2020	572	2,325	$207,302
2021	602	2,301	$231,668
2022	529	1,902	$177,751
2023	554	2,060	$185,624
2024	556	2,406	$164,750

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	239	3,157	$308,083
2016	249	2,985	$319,425
2017	254	2,705	$264,820
2018	299	2,858	$166,478
2019	332	2,888	$180,536
2020	339	2,590	$139,676
2021	336	2,299	$149,396
2022	342	2,336	$134,850
2023	373	2,642	$196,885
2024	457	3,212	$452,758

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	254	$18,940
2016	N/R	207	$7,505
2017	N/R	143	$3,607
2018	N/R	179	$6,146
2019	N/R	172	$4,631
2020	N/R	140	$8,588
2021	N/R	97	$2,811
2022	N/R	165	$7,017
2023	N/R	309	$9,015
2024	N/R	208	$4,260

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	128	261	$83
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	253	500	$62
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	169	497	$55
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	54	98	$36
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	244	406	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tavneos	Avacopan	12	360	$201,636
Farxiga	Dapagliflozin Propanediol	78	3,590	$65,732
Jardiance	Empagliflozin	51	3,090	$58,394
Eliquis	Apixaban	18	540	$10,241
Torsemide	Torsemide	396	27,318	$10,009

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	53	$979
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	35	$890
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	15	$805
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	57	$727
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	26	$532

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$63	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas Shaughnessy, M.D.?

Tedicare shows public-source Medicare data for Thomas Shaughnessy, M.D. (NPI 1326083379), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Shaughnessy, M.D. have ACO affiliation data?

Thomas Shaughnessy, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Thomas Shaughnessy, M.D.?

Thomas Shaughnessy, M.D. is linked to KIDNEY AND HYPERTENSION CENTER INC (billing NPI 1306944871) in the available physician profile data.

Does Thomas Shaughnessy, M.D. have Open Payments data?

Thomas Shaughnessy, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.